Fusion activity of HIV gp41 fusion domain is related to its secondary structure and depth of membrane insertion in a cholesterol-dependent fashion

Journal of Molecular Biology

Volumn 418, Issue 1-2, 2012, Pages 3-15

  Lai, Alex L ^a   Moorthy, Anna Eswara ^a   Li, Yinling ^a   Tamm, Lukas K ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

Author keywords

cholesterol; fusion domain; HIV; lipid bilayers; structure

Indexed keywords

CHOLESTEROL; GLYCOPROTEIN GP 41; LIPOSOME;

ALPHA HELIX; ARTICLE; BETA SHEET; CHANNEL GATING; CIRCULAR DICHROISM; ELECTRON SPIN RESONANCE; ENVIRONMENTAL TEMPERATURE; FLUORESCENCE RESONANCE ENERGY TRANSFER; LIPID BILAYER; LIPID COMPOSITION; MEMBRANE FUSION; MOLECULAR DOCKING; NONHUMAN; PRIORITY JOURNAL; PROTEIN SECONDARY STRUCTURE;

HUMAN IMMUNODEFICIENCY VIRUS;

EID: 84862778676     PISSN: 00222836     EISSN: 10898638     Source Type: Journal    
DOI: 10.1016/j.jmb.2012.02.010     Document Type: Article

References (31)

1. Harrison S.C. Viral membrane fusion Nat. Struct. Mol. Biol. 15 2008 690 698 (Pubitemid 351932011)
2. Lai A.L.; Li Y.; and Tamm L.K. Interplay of protein and lipids in virus entry by membrane fusion L.K. Tamm, Protein-Lipid Interactions 2005 Wiley-VCH Weinheim, Germany 279 303
3. Melikyan G.B. Membrane fusion mediated by human immunodeficiency virus envelope glycoprotein Curr. Top. Membr. 68 2011 81 106
4. Lalezari J.P.; DeJesus E.; Northfelt D.W.; Richmond G.; Wolfe P.; and Haubrich R. A controlled phase II trial assessing three doses of enfuvirtide (T-20) in combination with abacavir, amprenavir, ritonavir and efavirenz in non-nucleoside reverse transcriptase inhibitor-naive HIV-infected adults Antiviral Ther. 8 2003 279 287 (Pubitemid 37101630)
5. Ashkenazi A.; Wexler-Cohen Y.; and Shai Y. Multifaceted action of Fuzeon as virus-cell membrane fusion inhibitor Biochim. Biophys. Acta 1808 2011 2352 2358
6. Rafalski M.; Lear J.D.; and Degrado W.F. Phospholipid interactions of synthetic peptides representing the N-terminus of HIV gp41 Biochemistry 29 1990 7917 7922 (Pubitemid 20281241)
7. Martin I.; Schaal H.; Scheid A.; and Ruysschaert J.M. Lipid membrane fusion induced by the human immunodeficiency virus type 1 gp41 N-terminal extremity is determined by its orientation in the lipid bilayer J. Virol. 70 1996 298 304 (Pubitemid 126508798)
8. Nieva J.L.; Nir S.; Muga A.; Goni F.M.; and Wilschut J. Interaction of the HIV-1 fusion peptide with phospholipid-vesicles-different structural requirements for fusion and leakage Biochemistry 33 1994 3201 3209 (Pubitemid 24112630)
9. Peisajovich S.G.; Epand R.F.; Pritsker M.; Shai Y.; and Epand R.M. The polar region consecutive to the HIV fusion peptide participates in membrane fusion Biochemistry 39 2000 1826 1833 (Pubitemid 30108975)
10. Jaroniec C.P.; Kaufman J.D.; Stahl S.J.; Viard M.; Blumenthal R.; Wingfield P.T.; and Bax A. Structure and dynamics of micelle-associated human immunodeficiency virus gp41 fusion domain Biochemistry 44 2005 16167 16180 (Pubitemid 41785815)
11. Li Y.; and Tamm L. Structure and plasticity of the human immunodeficiency virus gp41 fusion domain in lipid micelles and bilayers Biophys. J. 93 2007 876 885 (Pubitemid 47219779)
12. Yang J.; Gabrys C.M.; and Weliky D.P. Solid-state nuclear magnetic resonance evidence for an extended beta strand conformation of the membrane-bound HIV-1 fusion peptide Biochemistry 40 2001 8126 8137 (Pubitemid 32641210)
13. Qiang W.; Bodner M.L.; and Weliky D.P. Solid-state NMR spectroscopy of human immunodeficiency virus fusion peptides associated with host-cell-like membranes: 2D correlation spectra and distance measurements support a fully extended conformation and models for specific antiparallel strand registries J. Am. Chem. Soc. 130 2008 5459 5471 (Pubitemid 351612954)
14. Schmick S.D.; and Weliky D.P. Major antiparallel and minor parallel beta sheet populations detected in the membrane-associated human immunodeficiency virus fusion peptide Biochemistry 49 2010 10623 10635
15. Saez-Cirion A.; and Nieva J.L. Conformational transitions of membrane-bound HIV-1 fusion peptide Biochim. Biophys. Acta 1564 2002 57 65 (Pubitemid 34717869)
16. Gordon L.M.; Mobley P.W.; Pilpa R.; Sherman M.A.; and Waring A.J. Conformational mapping of the N-terminal peptide of HIV-1 gp41 in membrane environments using (13)C-enhanced Fourier transform infrared spectroscopy Biochim. Biophys. Acta 1559 2002 96 120 (Pubitemid 34164420)
17. Qiang W.; and Weliky D.P. HIV fusion peptide and its cross-linked oligomers: efficient syntheses, significance of the trimer in fusion activity, correlation of beta strand conformation with membrane cholesterol, and proximity to lipid headgroups Biochemistry 48 2009 289 301
18. Qiang W.; Sun Y.; and Weliky D.P. A strong correlation between fusogenicity and membrane insertion depth of the HIV fusion peptide Proc. Natl Acad. Sci. USA 106 2009 15314 15319
19. Brugger B.; Glass B.; Haberkant P.; Leibrecht I.; Wieland F.T.; and Krausslich H.G. The HIV lipidome: a raft with an unusual composition Proc. Natl Acad. Sci. USA 103 2006 2641 2646
20. Columbus L.; and Hubbell W.L. A new spin on protein dynamics Trends Biochem. Sci. 27 2002 288 295 (Pubitemid 34628668)
21. Tamm L.K.; Lai A.L.; and Li Y. Combined NMR and EPR spectroscopy to determine structures of viral fusion domains in membranes Biochim. Biophys. Acta 1768 2007 3052 3060 (Pubitemid 350236096)
22. Altenbach C.; Greenhalgh D.A.; Khorana H.G.; and Hubbell W.L. A collision gradient method to determine the immersion depth of nitroxides in lipid bilayers: application to spin-labeled mutants of bacteriorhodopsin Proc. Natl Acad. Sci. USA 91 1994 1667 1671 (Pubitemid 24080266)
23. Han X.; Bushweller J.H.; Cafiso D.S.; and Tamm L.K. Membrane structure and fusion-triggering conformational change of the fusion domain from influenza hemagglutinin Nat. Struct. Biol. 8 2001 715 720 (Pubitemid 32757933)
24. Li Y.; Han X.; Lai A.L.; Bushweller J.H.; Cafiso D.S.; and Tamm L.K. Membrane structures of the hemifusion-inducing fusion peptide mutant G1S and the fusion-blocking mutant G1V of influenza virus hemagglutinin suggest a mechanism for pore opening in membrane fusion J. Virol. 79 2005 12065 12076 (Pubitemid 41279323)
25. Lai A.L.; Park H.; White J.M.; and Tamm L.K. Fusion peptide of influenza hemagglutinin requires a fixed angle boomerang structure for activity J. Biol. Chem. 281 2006 5760 5770 (Pubitemid 43847675)
26. Lai A.L.; and Tamm L.K. Locking the kink in the influenza hemagglutinin fusion domain structure J. Biol. Chem. 282 2007 23946 23956 (Pubitemid 47328033)
27. Jayasinghe S.; Hristova K.; and White S.H. Energetics, stability, and prediction of transmembrane helices J. Mol. Biol. 312 2001 927 934 (Pubitemid 32980315)
28. Tamm L.K. Hypothesis: spring-loaded boomerang mechanism of influenza hemagglutinin-mediated membrane fusion Biochim. Biophys. Acta 1614 2003 14 23 (Pubitemid 36851600)
29. Han X.; and Tamm L.K. A host-guest system to study structure-function relationships of membrane fusion peptides Proc. Natl Acad. Sci. USA 97 2000 13097 13102
30. Ames B.N. Assay of inorganic phosphate, total phosphate, and phosphatases Methods Enzymol. 8 1966 115 118
31. Langen R.; Oh K.J.; Cascio D.; and Hubbell W.L. Crystal structures of spin labeled T4 lysozyme mutants: implications for the interpretation of EPR spectra in terms of structure Biochemistry 39 2000 8396 8405 (Pubitemid 30489936)